Article Details
Retrieved on: 2021-03-19 05:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In February this year, the company announced it will demerge and list its biotech business under Stelis Biopharma in the next 12 months. Former ...
Article found on: www.bloombergquint.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here